Cochrane Abstracts
GLP‐1 receptor agonists for Parkinson's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"GLP‐1 Receptor Agonists for Parkinson's Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436930/0/GLP‐1_receptor_agonists_for_Parkinson's_disease.
GLP‐1 receptor agonists for Parkinson's disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436930/0/GLP‐1_receptor_agonists_for_Parkinson's_disease. Accessed April 8, 2025.
GLP‐1 receptor agonists for Parkinson's disease. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436930/0/GLP‐1_receptor_agonists_for_Parkinson's_disease
GLP‐1 Receptor Agonists for Parkinson's Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 April 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436930/0/GLP‐1_receptor_agonists_for_Parkinson's_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - GLP‐1 receptor agonists for Parkinson's disease
ID - 436930
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436930/0/GLP‐1_receptor_agonists_for_Parkinson's_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
